Ion pair skin transport of a zwitterionic drug, cephalexin

Journal of Controlled Release

Volumn 66, Issue 1, 2000, Pages 63-71

  Hatanaka, Tomomi ^a   Kamon, Toshihiko ^a   Morigaki, Setsuko ^a   Katayama, Kazunori ^a   Koizumi, Tamotsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cephalexin; Counter ion; Ion pair; Skin transport; Zwitterionic drug

Indexed keywords

ALCOHOL; AMPHOLYTE; CEFALEXIN; CORTISONE; MANNITOL; TETRABUTYLAMMONIUM; TETRAMETHYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIELECTRIC CONSTANT; DRUG TRANSPORT; ION TRANSPORT; LIPOPHILICITY; MALE; NONHUMAN; PARTITION COEFFICIENT; PH; PRIORITY JOURNAL; RAT; SKIN PENETRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; BUFFERS; CEPHALEXIN; CEPHALOSPORINS; CORTISONE; DIFFUSION; DIURETICS, OSMOTIC; HYDROGEN-ION CONCENTRATION; MALE; MANNITOL; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SOLUBILITY;

EID: 0034600191     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00259-X     Document Type: Article

References (27)

1. Higuchi W.I., Gordon N.A., Fox J.L., Ho N.F.H. Transdermal delivery of prodrugs. Drug Dev. Ind. Pharm. 9:1983;691-706.
2. Walters K.A. Penetration enhancers and their use in transdermal therapeutic systems. Hadgraft J., Guy R.H. Transdermal Drug Delivery. 1989;197-246 Marcel Dekker, New York.
3. Sloan J.B. Iontophoresis in dermatology. J. Am. Acad. Dermatol. 15:1986;671-684.
4. Kost J., Langer R. Ultrasound-mediated transdermal drug delivery. Shah V.P., Maibach H.I. Topical Drug Bioavailability, Bioequivalence, and Penetration. 1993;91-104 Plenum Press, New York.
5. Neubert R. Ion pair transport across membranes. Pharm. Res. 6:1989;743-747.
6. Kraus C.A. The ion pair concept: Its evolution and some applications. J. Phys. Chem. 60:1956;129-141.
7. Hadgraft J., Walters K.A., Wotton R.K. Facilitated percutaneous absorption: a comparison and evaluation of two in vitro models. Int. J. Pharm. 32:1986;257-263.
8. Langguth P., Mutschler E. Lipophilization of hydrophilic compounds: Consequences on transepidermal and intestinal transport of trospium chloride. Arzneim. Forsch. Drug Res. 37:1987;1362-1366.
9. Green P.G., Hadgraft J., Wolff M. Physicochemical aspects of the transdermal delivery of bupranolol. Int. J. Pharm. 55:1989;265-269.
10. Kurihara-Bergstrom T., Lin P. Enhanced in vitro skin transport of ionized terbutaline using its sulfate salt form in aqueous isopropanol. STP Pharma Sci. 1:1991;52-59.
11. Pardo A., Shin Y., Cohen S. Kinetics of transdermal penetration of an organic ion pair: Physostigmine salicylate. J. Pharm. Sci. 81:1992;990-995.
12. Nash R.A., Mehta D.B., Matias J.R., Orentreich N. The possibility of lidocaine ion pair absorption through excised hairless mouse skin. Skin Pharmacol. 5:1992;160-170.
13. Trotta M., Pattarino F., Gasco M.R. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm. Acta Helv. 71:1996;135-140.
14. Quintanar-Guerrero D., Allémann E., Fessi H., Doelker E. Applications of the ion-pair concept to hydrophilic substances with special emphasis on peptides. Pharm. Res. 14:1997;119-127.
15. Hatanaka T., Morigaki S., Aiba T., Katayama K., Koizumi T. Effect of pH on the skin permeability of a zwitterionic drug, cephalexin. Int. J. Pharm. 125:1995;195-203.
16. International Critical Tables, Vol. VI, McGraw-Hill, New York, 1949.
17. Hatanaka T., Kamon T., Uozumi C., Morigaki S., Aiba T., Katayama K., Koizumi T. Influence of pH on skin permeation of amino acids. J. Pharm. Pharmacol. 48:1996;675-679.
18. Hatanaka T., Shimoyama M., Sugibayashi K., Morimoto Y. Effect of vehicle on the skin permeability of drugs: polyethylene glycol 400-water and ethanol-water binary solvents. J. Control. Release. 23:1993;247-260.
19. Ashton P., Walters K.A., Brain K.R., Hadgraft J. Surfactant effects in percutaneous absorption. I. Effects on the transdermal flux of methyl nicotinate. Int. J. Pharm. 87:1992;261-264.
20. Aungst B.J., Blake J.A., Hussain M.A. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7:1990;712-718.
21. Cumming K.I., Winfield A.J. In vitro evaluation of a series of sodium carboxylates as dermal penetration enhancers. Int. J. Pharm. 108:1994;141-148.
22. Adjei A., Rao S., Garren J., Menon G., Vadnere M. Effect of ion-pairing on 1-octanol-water partitioning of peptide drugs. I. The nonapeptide leuprolide acetate. Int. J. Pharm. 90:1993;141-149.
23. Schill G. Isolation of drugs and related organic compounds by ion-pair extraction. Marinsky J.A., Marcus Y. Ion Exchange and Solvent Extraction. 1974;1-57 Marcel Dekker, New York.
24. Lee S.J., Kim S.W. Hydrophobization of ionic drugs for transport through membranes. J. Control. Release. 6:1987;3-13.
25. Liu P., Kurihara-Bergstrom T., Clarke F.H., Gonnella N., Good W.I. Quantitative evaluation of aqueous isopropanol enhancement of skin flux of terbutaline (sulfate). I. Ion associations and species equilibria in the formation. Pharm. Res. 9:1992;1035-1042.
26. Ghanem A.H., Mahmoud H., Higuchi W.I., Rohr U.D., Borsadia S., Liu P., Fox J.L., Good W.R. The effect of ethanol on the transport of β-estradiol and other permeants in hairless mouse skin. II. A new quantitative approach. J. Control. Release. 6:1987;75-83.
27. Møllgaard B. Synergistic effects in percutaneous enhancement. Walter K.A., Hadgraft J. Pharmaceutical Skin Penetration Enhancement. 1993;229-242 Marcel Dekker, New York.